Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
暂无分享,去创建一个
N. Maniadakis | J. Espín | Z. Kaló | A. Inotai | T. Tesar | K. Podrazilová | F. Fricke | Z. Petykó
暂无分享,去创建一个
N. Maniadakis | J. Espín | Z. Kaló | A. Inotai | T. Tesar | K. Podrazilová | F. Fricke | Z. Petykó